Literature DB >> 2265090

Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis.

A Y Finlay1, G K Khan, D K Luscombe, M S Salek.   

Abstract

A prospective cross-sectional questionnaire study of 32 patients with psoriasis was carried out in order to validate the use of the Sickness Impact Profile (SIP) in psoriasis and compare its sensitivity with the Psoriasis Disability Index (PDI). Overall PDI scores, but not overall SIP scores, correlated well with PASI scores (P less than 0.05). There was good correlation between the PDI and overall SIP scores (P less than 0.01). Psychosocial factors are more severely impaired than physical activities in patients with psoriasis. It is now possible to directly compare the disability experienced by psoriatic patients with that experienced by patients suffering from other systemic diseases, using the SIP. The PDI is an appropriate method to give a rapid overall measure of psoriasis disability.

Entities:  

Mesh:

Year:  1990        PMID: 2265090     DOI: 10.1111/j.1365-2133.1990.tb04192.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  40 in total

1.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

Review 2.  A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research.

Authors:  R T Anderson; N K Aaronson; M Bullinger; W L McBee
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 3.  Measuring health status? A review of the sickness impact and functional limitations profiles.

Authors:  S J Williams
Journal:  Health Care Anal       Date:  1996-11

4.  [Psychosocial consequences of psoriasis--an empirical study of disease burden in 3753 affected people].

Authors:  G Schmid-Ott; P Malewski; I Kreiselmaier; U Mrowietz
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

5.  Questionnaire techniques in assessing acne handicap: reliability and validity study.

Authors:  M S Salek; G K Khan; A Y Finlay
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

6.  Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.

Authors:  Maria Flávia Pereira da Silva; Maria Rita Parise Fortes; Luciane Donida Bartoli Miot; Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

7.  Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms.

Authors:  Vera Almeida; Sofia Taveira; Maribel Teixeira; Isabel Almeida; José Rocha; Ana Teixeira
Journal:  Int J Behav Med       Date:  2017-08

8.  Effect of store and forward teledermatology on quality of life: a randomized controlled trial.

Authors:  John D Whited; Erin M Warshaw; Karen E Edison; Kush Kapur; Lizy Thottapurathu; Srihari Raju; Bethany Cook; Holly Engasser; Samantha Pullen; Patricia Parks; Tom Sindowski; Danuta Motyka; Rodney Brown; Thomas E Moritz; Santanu K Datta; Mary-Margaret Chren; Lucinda Marty; Domenic J Reda
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

9.  Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.

Authors:  Jaroslav Chládek; Jiøí Grim; Jiøina Martínková; Marie Simková; Jaroslava Vanìèková; Vìra Koudelková; Marie Noièková
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

10.  Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).

Authors:  Mayke B G Koek; Erik Buskens; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Vigfús Sigurdsson
Journal:  BMJ       Date:  2009-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.